FI4136091T3 - Plasman kallikreiinin estäjien muotoja ja koostumuksia - Google Patents

Plasman kallikreiinin estäjien muotoja ja koostumuksia

Info

Publication number
FI4136091T3
FI4136091T3 FIEP21724430.0T FI21724430T FI4136091T3 FI 4136091 T3 FI4136091 T3 FI 4136091T3 FI 21724430 T FI21724430 T FI 21724430T FI 4136091 T3 FI4136091 T3 FI 4136091T3
Authority
FI
Finland
Prior art keywords
solid form
compound
diffractions
xrpd
theta
Prior art date
Application number
FIEP21724430.0T
Other languages
English (en)
Finnish (fi)
Inventor
Suresh Kumar Tipparaju
Jeffrey Scott Depue
Helge Alfred Reisch
Samuel Alexander Stratford
Joseph Stephen Harris
Sarah Jocelyn Fink
Nikolaos Papaioannou
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of FI4136091T3 publication Critical patent/FI4136091T3/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FIEP21724430.0T 2020-04-17 2021-04-16 Plasman kallikreiinin estäjien muotoja ja koostumuksia FI4136091T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063011776P 2020-04-17 2020-04-17
PCT/US2021/027620 WO2021211930A1 (en) 2020-04-17 2021-04-16 Forms and compositions of inhibitors of plasma kallikrein

Publications (1)

Publication Number Publication Date
FI4136091T3 true FI4136091T3 (fi) 2025-07-25

Family

ID=75870731

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP21724430.0T FI4136091T3 (fi) 2020-04-17 2021-04-16 Plasman kallikreiinin estäjien muotoja ja koostumuksia

Country Status (9)

Country Link
US (1) US20230167132A1 (https=)
EP (2) EP4623913A3 (https=)
JP (2) JP2023522331A (https=)
DK (1) DK4136091T3 (https=)
ES (1) ES3035604T3 (https=)
FI (1) FI4136091T3 (https=)
PL (1) PL4136091T3 (https=)
PT (1) PT4136091T (https=)
WO (1) WO2021211930A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028362A1 (en) * 2017-08-04 2019-02-07 Dyax Corp. INHIBITORS OF PLASMATIC KALLIKREIN AND USES THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
EP1596869B1 (en) * 2003-01-21 2014-06-04 New Form Pharmaceuticals Inc. Novel cocrystallization
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN110015955A (zh) * 2010-07-23 2019-07-16 格吕伦塔尔有限公司 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体
WO2012097333A2 (en) * 2011-01-14 2012-07-19 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
EP3765459A1 (en) 2018-03-13 2021-01-20 Shire Human Genetic Therapies, Inc. Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof

Also Published As

Publication number Publication date
PL4136091T3 (pl) 2025-08-18
ES3035604T3 (en) 2025-09-05
WO2021211930A1 (en) 2021-10-21
EP4136091A1 (en) 2023-02-22
EP4136091B1 (en) 2025-05-28
EP4623913A2 (en) 2025-10-01
US20230167132A1 (en) 2023-06-01
WO2021211930A8 (en) 2021-12-16
JP2023522331A (ja) 2023-05-30
JP2025142238A (ja) 2025-09-30
PT4136091T (pt) 2025-08-22
EP4623913A3 (en) 2025-12-24
DK4136091T3 (da) 2025-08-18

Similar Documents

Publication Publication Date Title
US20150141383A1 (en) Darunavir Polymorph and Process for Preparation Thereof
CA3125504A1 (en) Solid forms of treprostinil
FI4136091T3 (fi) Plasman kallikreiinin estäjien muotoja ja koostumuksia
SA517381904B1 (ar) شكل بلوري جديد لمشتق بنزيميدازول وطريقة تحضيره
KR20180011783A (ko) 삼나트륨 발사르탄:사쿠비트릴의 고체 형태
JP2025169363A (ja) ７ｈ－ベンゾ［７］アヌレン－２－カルボン酸誘導体の結晶形態
JP2022104995A (ja) 結晶
EP3173400A1 (de) Kristalline modifikationen von (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
TW201629062A (zh) 二氮雜雙環辛烷衍生物之結晶及安定的凍結乾燥製劑的製造法
CA2971826A1 (en) Crystal forms of apomorphine and uses thereof
AU2021281365A1 (en) Solid forms of pralsetinib
CN112469717B (zh) 用于纯化艾沙康唑鎓硫酸盐的方法
WO2007013086A1 (en) Novel polymorphs of tenofovir disoproxil fumarate
JP2019529481A5 (https=)
US20240300949A1 (en) Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hemisuccinate
WO2008100651A2 (en) Preparation of darifenacin and its salts
US20150322084A1 (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
JP2024508378A (ja) ジフェニルピラジン誘導体の製造プロセス
JP2012511006A (ja) アザビシクロ−トリフルオロメチルベンズアミド誘導体の新規な結晶多形
US20110263616A1 (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
JP2023522331A5 (https=)
CN121368596A (zh) 抗病毒前药的晶型
WO2018229613A1 (en) Solid forms of acalabrutinib and process for preparation thereof
JP7617043B2 (ja) ｔｅｒｔ－ブチル（Ｓ）－２－（（２Ｓ，３Ｒ）－１－アミノ－３－ヒドロキシ－１－オキソブタン－２－イル）－１－オキソ－２，５－ジアザスピロ［３．４］オクタン－５－カルボキシレートの固体形態およびそれらを調製する方法
CN117412968A (zh) 1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺硫酸氢盐一水合物的新晶型